The advice you hear most often about content is: keep it short. Cut it down. Make it digestible.

That is not wrong. It is just not the whole truth.

Audiences are not attention-deficient. They are patient-deficient when content wastes their time. There is a difference, and in medtech, where every story you tell connects to a clinical decision or a patient outcome, that difference is worth understanding.

Story guiding is the discipline of shaping how an audience moves through information and arrives somewhere useful. Not just informed. Useful. Here is what that looks like in practice.

Stories don’t have to be shorter. They must be sharper.

Think about the last long piece you finished. You did not finish it because it was short. You finished it because it held you. Research on reading and sustained attention finds that longer formats engage a qualitatively different kind of focus: one that short-form content does not reach and cannot build.

People subscribe to clinical journals, follow trial updates for months, and stay with a three-hour documentary until the credits roll. What they will not do is stay with content that has not earned their time. Sharpening a story is not about cutting it down. It is about making every word do something: earn attention, build understanding, establish trust. That requires judgment, not a word count target.

Simplify the message. Not the meaning.

There is a version of “keeping it simple” that condescends. In medtech, clinical audiences notice immediately, and they leave. The precision of the technology, the clinical evidence behind it, the workflow implications: these are not details to sand down for readability. They are the reasons your audience trusts you. Simplifying means choosing the right detail and the right language. It does not mean removing the substance that makes the story worth reading.

The right level of detail.

Everyone on a care team cares about workflow. But what counts as proof is not the same for every role, and a story that moves one person in the room can fall flat for the person sitting next to them. A teaser can open a door. It cannot close a case. The skill is understanding what each audience needs to hear before they trust what you are telling them and then giving them exactly that. Not more. Not less. The evidence that resonates.

Attention is not the problem. Relevance is.

In medtech, relevance is specific. It is produced by genuine understanding of what your audience is facing: reimbursement pressures, workflow constraints, the evidence threshold they need before they will change clinical practice and outcomes. Speak to that reality and people stay with you.

What this looks like in medtech

Recently I found myself deep in a long-form piece about a cancer study. The subjects were golden retrievers. The study has been running for 14 years, following thousands of dogs to understand the nutritional, environmental, and genetic factors that drive cancer, because what happens in dogs maps more closely to human disease than most people realize. I stayed with it not because it was short. Because it was specific, honest, and written for someone who wanted to understand it.

That is the standard.

Content that sounds credible to a general audience can sound imprecise to a clinical one. If your story is not landing, ask whether your audience has what they need to trust it. That is usually where the answer lives.

That calibration is the work. At G3 Medical Marketing, it is what we bring to every project. If you want to talk about yours, reach out.

Michelle Joiner | Global Communications Director, Radiation Oncology and Medtech | G3 Medical Marketing